Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872856 · ClinicalTrials.gov registry record · NA
Blood Pressure-Improving Control Among Alaska Native People" (BP-ICAN)
A NA study, sponsored by Southcentral Foundation.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT03872856 is a NA study that has completed, run by Southcentral Foundation. The registered enrollment target is 164 participants.
The verdict
NCT03872856, a NA study, has completed, sponsored by Southcentral Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
"Blood Pressure: Improving Control among Alaska Native People" (BP-ICAN) that targets blood pressure control among Alaska Native and American Indian (AN/AI) people diagnosed with hypertension. Participants will include adults with a diagnosis of hypertension who have not achieved blood pressure control. Primary Care Center (PCC) provider teams and associated panels of Alaska Native or American Indian (ANAI) adults will be randomized into the control or intervention arm. The investigators will recruit up to 10 ANAI adults per PCC provider for a total of 324 participants. Intervention participants will receive a home blood pressure monitor (HBPM), upload personal home blood pressure values into a data mall, and be encouraged to communicate with providers and pharmacists about HBPM results using an online electronic health record application, telephone, or other existing clinical processes. HBPM measurements for each intervention arm participant will be provided to provider teams and integrated pharmacists. Control participants will receive care as usual. Data will be collected over a 12 month period. Participants will meet with investigators at time of consent (baseline), and 3, 6, and 12 months after baseline. At each visit, participants will have blood pressure measured using 3 methods (aneroid sphygmomanometer, automated Omron upper arm cuff device, and automated Omron wrist cuff device), complete surveys, and have height, weight, and arm circumference measured. In-person measures are omitted during the pandemic and only one method of blood pressure measurement is used (upper arm cuff device). Clinical and service utilization information will be electronically queried with participant consent. The investigators will examine whether participants in the intervention arm have better blood pressure control at the end of the 12 month period than participants in the control arm.
Interventions
- DEVICE BP-ICAN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03872856
The ClinicalTrials.gov registry entry for NCT03872856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southcentral Foundation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BP-ICAN is the first listed.
NCT03872856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03872856 about?
NCT03872856 is a clinical study titled "Blood Pressure-Improving Control Among Alaska Native People" (BP-ICAN)". "Blood Pressure: Improving Control among Alaska Native People" (BP-ICAN) that targets blood pressure control among Alaska Native and American Indian (AN/AI) people diagnosed with hypertension. Participants will include adults with a diagnosis of hypertension who have not achieved blood pressure cont...
What is the current status of trial NCT03872856?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2019-02-19. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT03872856?
The interventions under investigation include: BP-ICAN (DEVICE).
Who is sponsoring clinical trial NCT03872856?
This trial is sponsored by Southcentral Foundation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.